共 50 条
- [1] Discontinuation of somatostatin analogs while acromegaly is in long-term remission Pituitary, 2015, 18 : 554 - 560
- [4] Long-term efficacy and safety of combined treatment of somatostatin analogs and Pegvisomant in acromegaly JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4598 - 4601
- [5] Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10): : 3644 - 3652
- [6] Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09): : 4142 - 4146
- [7] LONG-TERM BROMOCRIPTINE TREATMENT AND SOMATOSTATIN IN ACROMEGALY ENDOKRINOLOGIE, 1980, 76 (02): : 152 - 162
- [8] Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues ENDOCRINE CONNECTIONS, 2016, 5 (04): : 167 - 173
- [9] Long-term effects of pegvisomant in patients with acromegaly NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (06): : 324 - 332
- [10] Long-term effects of pegvisomant in patients with acromegaly Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 324 - 332